
2016 Annual Meeting
2016 Pre-Meeting Materials
Materials for Registrants Only
Evening Specialty Conferences
- Bone and Soft Tissue Pathology
- Breast Pathology
- Cardiovascular Pathology
- Cytopathology
- Dermatopathology
- Gastrointestinal Pathology
- Genitourinary Pathology
- Gynecologic Pathology
- Head and Neck/Endocrine Pathology
- Hematopathology
- Infectious Disease Pathology
- Liver Pathology
- Neuropathology
- Ophthalmic Pathology
- Pediatric Pathology
- Pulmonary Pathology
- Renal Pathology
- Surgical Pathology
Companion Society Meetings
American Association of Neuropathologists | ||
---|---|---|
If This is Not Glioblastoma, Then What is It? | Murat Gokden, MD | |
What do I do with this low Grade Glioma? | Craig Horbinski, MD, PhD | |
How Do I Report this Embryonal Tumor? | Maria Martinez-Lage Alvarez, MD |
American Association of Ocular Oncologists and Pathologists | ||
---|---|---|
Primary Orbital Tumors | Sander Dubovy, MD | |
Bone and Orbital Wall Lesions | Tatyana Milman, MD | |
Inflammatory and Benign Orbital Lesions | Diva Salomao, MD |
American Society for Clinical Pathology | ||
---|---|---|
Communicating with Colleagues, Treating Clinicians and Patients | Suzanne Dintzis, MD, PhD | |
Improving Diagnosis in Health Care: Impact in Pathology | Thomas Gallagher, MD | |
High Reliability Practice and Safety Culture | Omar Hameed, MD |
American Society for Cytopathology | ||
---|---|---|
Cytology/Biopsy/LEEP Correlation - Practical Considerations and Approaches | Fadi W. Abdul-Karim, MD | |
The New Diagnostic Paradigms in Thyroid Surgical Pathology and Effects on Reporting of Thyroid Fine-Needle Aspiration Specimens | Zubair W. Baloch, MD, PhD | |
Glandular Lesions on Pap - Still Difficult After All These Years | Dina Mody, MD | |
Time to Standardize the Cytology Reporting of Salivary Glands - Introduction of the Milan System | William Faquin, MD, PhD | |
In an Era of Personalized Approach to Lung Cancer - -Which Type of Specimen Rules Supreme? | Swati Mehrotra, MD | |
Everything is Spindle - How Far Can We Go With Limited Material? | Paul Wakely, Jr., MD |
American Society for Investigative Pathology | ||
---|---|---|
Immune Targeting in Breast Cancer | Ashley Cimino-Mathews, MD | |
Cancer Immunotherapy: The Role of the Pathologist in the Oncology Team | James C. Yang, MD | |
Benchtop to Bedside:Evolution of Molecular Classification of Lung Cancer | Neal Lindeman, MD | |
Intro to the ASIP Comapnion Meeting | Mark E. Sobel, MD, PhD | |
Integrated Morphologic and Molecular Glioma Diagnostics Based on the 2016 WHO Classification Scheme | Arie Perry, MD |
American Society of Dermatopathology | ||
---|---|---|
Dermatopathology Insights from Pathology Consults - Cases I Remember and Learned From | Asok Biswas, MD, FRCPath, DipRCPath | |
Cases I Remember and Learned From | Mai Hoang, MD | |
Eruptive Keratoacanthoma En Plaque | Rossitza Lazova, MD |
Arthur Purdy Stout Society of Surgical Pathologists | ||
---|---|---|
Urologic Pathology | Pedram Argani, MD | |
Neuropathology | Daniel J. Brat, MD, PhD | |
Hepatic Pathology | Sanjay Kakar, MD | |
Thyroid Pathology | Yuri. E. Nikiforov, MD, PhD | |
How has Molecular Diagnostics Changed my Practice? | Lynette M. Sholl, MD | |
Head and Neck Pathology | Ilan Weinreb, MD |
Association for Molecular Pathology | ||
---|---|---|
Molecular Monitoring in AML Can Inform Prognosis | Jeffery M. Klco, MD, PhD | |
Cell-free Tumor DNA for Cancer Monitoring | Christina Lockwood, PhD, DABCC, FACB | |
Clinical Application of NGS for MRD Monitoring in Lymphoid Neoplasms | David Wu, MD, PhD | |
New Insights into Molecular Monitoring in Cancer | Eric Duncavage, MD |
Association for Pathology Informatics | ||
---|---|---|
Stromal/Tumor Interaction and Digital Analysis | Andrew Beck, MD | |
Image Analysis in Current Clinical Practice | Liron Pantanowitz, MD | |
Whole Slise Imaging In Imaging Research and Clinical Research | Yukako Yagi, PhD | |
Automated Differential Diagnosis | Ulysses Balis, MD | |
Mutiplex Immunohistochemistry | Michael Feldman, MD |
Binford - Dammin Society of Infectious Disease Pathologists | ||
---|---|---|
Fungal Infections of the Lung: Histopathology and Molecular Diagnosis | Jeannette Guarner, MD and Andrew Bryan, MD, PhD | |
Parasitic Infections of the Lung and Infectious Mimics | Bobbi Pritt, MD, MSc, DTM&H | |
Viral Infections of the Lung, Including Influenza and Emerging Infections: Histopathology and Molecular Diagnosis | Atis Muehlenbachs, MD, PhD |
College of American Pathologists | ||
---|---|---|
Introduction | Robert M. Najarian, MD | |
HER2 Testing Guidelines for Adenocarcinomas of the Stomach and Gastroesophageal Junction | Angela N. Bartley, MD | |
Revision of the CAP/IASLC/AMP Molecular Testing Guideline for Lung Cancer Biomarkers | Philip T. Cagle, MD | |
HPV Testing in Head and Neck Carcinomas | William Faquin, MD, PhD | |
Molecular Markers for the Evaluation of Colorectal Cancer | Stanley R. Hamilton, MD | |
Recommendations for Human Epidermal Growth Factor 2 Testing in Breast Cancer | M. Elizabeth Hammond, MD |
Endocrine Pathology Society | ||
---|---|---|
Genomic Landscapes of Poorly-differentiated and Anaplastic Thyroid Carcinoma: Clues for Better Classification, Risk Stratification and Therapy | Ronald Ghossein, MD | |
Genomic Appraisal of Adrenocortical Carcinomas: What Practicing Pathologists Need to Know | Thomas Giordano, MD, PhD | |
Thyroid Carcinoma TCGA and Beyond: Impact on Thyroid Cancer | Yuri E. Nikiforv, MD, PhD | |
New Genetics Data of Pancreatic Neuroendocrine Tumors: Implications for Diagnosis, Treatment, and Targeted Therapies | Anja Schmitt Kurrer, MD |
Hans Popper Hepatopathology Society | ||
---|---|---|
Adult Presentation of Metabolic Liver Diseases | John Hart, MD | |
Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Revisited | Marcela Salomao, MD | |
Drug-Induced Liver Injury: Role of the Pathologist | Romil Saxena, MBBS, FRCPath | |
Pre-Invasive Neoplasia of the Biliary Tract | N. Volkan Adsay, MD | |
Atypical Well-Differentiated | Sanjay Kakar, MD | |
Meeting Call to Order and Intro Remarks | M. Isabel Fiel, MD | |
The"Overlap" Syndromes: Do They Exist | Kay washington, MD, PhD |
History of Pathology Society | ||
---|---|---|
Time-Travelling to the Origins of Lung Cancer | Anthony A. Gal, MD | |
Alfred's Morgagni Klemperer Crohn Disease | Stephen A. Geller, MD | |
How Neuropathologic Observations Have Determined the Treatment of Neurologic Diseases: An Historical Perspective | Harry Vinters, MD |
International Society of Bone and Soft Tissue Pathology | ||
---|---|---|
Ewing and Ewing-like Sarcomas | Cristina R. Antonescu, MD | |
SWI/SNF Dependent Tumors | Franois Le Loarer, MD | |
ALK Fusion Positive Mesenchymal Tumors | Jason L. Hornick, MD | |
GIST: From Leiomyoblastoma to Wild Type GIST | Markku M. Miettinen, MD | |
MDM2 Amplified Sarcomas | Raf Sciot, MD |
International Society of Breast Pathology | ||
---|---|---|
Breast cancer Diagnosis and Surgical Pathology A Critical Global Oncology Issue. | Benjamin O. Anderson, MD | |
How Ancillary Techniques may be Utilized to Improve Diagnostic Accuracy in Breast Pathology | Allen M. Gown, MD | |
How Good Are You At Breast Pathology? Lessons from the UK EQA Program | Ian O. Ellis, MD | |
Discrepant Diagnosis Where's the Harm? | Jean F. Simpson, MD |
International Society of Gynecological Pathologists | ||
---|---|---|
Identifying Lynch Syndrome in Patients with Gynecologic Cancers: Arriving Where We Started | Blaise Clark, MD | |
Hereditary Ovarian and Breast Cancer Syndrome | C. Blake Gilks, MD | |
Pathological and Molecular Features of Cowden and Peutz-Jeghers Syndrome | Xavier Matias-Guiu, MD, PhD | |
Importance of PCR-based Tumor Testing in the Evaluation of Lynch Syndrome | Russell Broaddus, MD, PhD, | |
Brave New Genomic World: Do We Still Need Clinical Cancer Geneticists, and if so, why? | Will Foulkes, MBBS, PhD | |
Uterine Mesenchymal Tumors: Hereditary Aspects | Karuna Garg, MD | |
DICER1 and SMARCA4 Mutations in Ovarian Neoplasia: Recent Developments | Esther Oliva, MD |
International Society of Urological Pathology | ||
---|---|---|
Introduction and Welcome from the ISUP | Lars Egevad, MD, PhD | |
Update on the 2016 WHO Classification of Prostate Neoplasia | Peter Humphrey, MD | |
Update on the 2016 WHO Classification of Kidney Neoplasia | Holger Moch, MD | |
Update on the 2016 WHO Classification of Bladder Neoplasia | Victor Reuter, MD | |
Update on the 2016 WHO Classification of Testicular Neoplasia | Thomas Ulbright, MD |
North American Society of Head and Neck Pathology | ||
---|---|---|
Xeroderma Pigmentosum Syndrome | Jennifer Black, MD | |
Basal Cell-nevus (Gorlin) Syndrome | Scott Granter, MD | |
Brooke-Spiegler Syndrome | Dmitry Kazakov, MD | |
Multiple Endocrine Neoplasia, Type llb | Peter M. Sadow. MD, PhD | |
Cowden-PTEN Syndrome | Vania Nose, MD, PhD |
Paleopathology Club | ||
---|---|---|
Black Death and White Plague in an English Medieval Cemetery | Jennifer Black, MD | |
Kuku and Pigbel: Diseases that have Disappeared from Papua New Guinea | Robin A. Cooke, MD | |
Paleopathology of Bone-Forming Conditions:Indicators of Culture and the Environment | Cynthia A. Wilczak |
Papanicolaou Society of Cytopathology | ||
---|---|---|
Update on Molecular Testing of Cytology Samples | Dara Aisner, MD, PhD | |
Do's and Don'ts of Immunohistochemistry of Limited Tissue Samples | Andrew Bellizzi, MD | |
Diagnosing Mesothelioma in Limited Tissue Samples | Sanja Dacic, MD, PhD | |
Regulatory and Cost Containment Issues Affecting Molecular Diagnostic Laboratory | Jennifer Hunt, MD |
Pulmonary Pathology Society | ||
---|---|---|
Cryobiopsy for Interstitial Lung Disease | Thomas V. Colby, MD and Sara Tomassetti, MD | |
Interstitial Lung Diseases: Why the Diagnosis Matters | Lynette Sholl, MD, Lida P. Hariri, MD, PhD and Sydney B. Montesi, MD | |
New Frontiers in Lung Cancer Diagnostics | Ming S. Tsao, MD |
Renal Pathology Society | ||
---|---|---|
Warfarin Nephropathy | Sergey V. Brodsky, MD, PhD | |
Bile Cast Nephropathy | Anthony Chang, MD, FASN | |
Membranous-like Glomerulopathy with Masked IgG kappa Deposits | Chris Larsen, MD | |
Mesoamerican Nephropathy | Annika Wernerson, MD |
Rodger C. Haggitt Gastrointestinal Pathology Society | ||
---|---|---|
What is the Weird Foreign material in the GI Specimen | Maria Fatima Carneiro, MD, PhD | |
Genetic Alterations in Gastrointestinal Stromal Tumors: Implications for Diagnosis and Management | Christopher Corless, MD, PhD | |
When I Choose to do a Lymphoma work up on a GI Biopsy | Scott Owen | |
How I Sign out Gastritis | Dora Lam-Himlin | |
New Developments in the Molecular Mechanisms Important in Pancreatic Cancer Pathogenesis | Ralph H. Hruban, MD | |
The Role of the Surgical Pathologist in the Diagnosis of Rare Polyposis Syndromes | Christophe Rosty, MD |
Society for Hematopathology | ||
---|---|---|
Dr. Hsi - Cases 1 through 3 | Eric D. Hsi, MD | |
Diagnosis and Follow-Up of B Lymphoblastic Leukemia | Brent L. Wood, MD, PhD | |
DLBCL, Nos from the Clinician Perspective | John P. Leonard, MD | |
Diagnosis of Diffuse Large B-cell Lymphoma | L. Jeffrey Medeiros, MD | |
Advances in the Genetics of B-Cell Precursor Acute Lymphoblastic Leukemia | Charles Mullighan, MBBS, MD | |
The Spectrum of EBV+ B-cell Lymphoproliferative Disorders | Yaso Natkunam, MD, PhD | |
Diffuse Large B-cell Lymphoma: Biomarkers for Precision Healthcare | Lisa M. Rimsza, MD |
Society for Ultrastructural Pathology | ||
---|---|---|
Small Blue Cell Tumors in Soft Tissue and Bone | Cyril Fisher, MD, DSc, FRCPath | |
Small Blue Cell Tumors in the Lung | Victor Roggli, MD | |
Small Blue Cell Tumors in Children | John Hicks, MD, PhD | |
Cytology of Small Blue Cell Tumors | Elba A. Turbat-Herrera, MD |
Society of Cardiovascular Pathology | ||
---|---|---|
Sudden Unexplained Death, The Molecular Autopsy, and Genetic Purgatory | Micheal J. Ackerman, MD, PhD | |
The Anatomic Pathology of Sudden Cardiac Death | Jeffrey E. Saffitz, MD, PhD | |
Molecular Investigation of sudden Cardiac Death: The New York Experience | Barbara Sampson, MD, PhD |